These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26847972)

  • 1. Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review.
    Leu-Semenescu S; Louis P; Arnulf I
    Sleep Med; 2016 Jan; 17():38-44. PubMed ID: 26847972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.
    Lavault S; Dauvilliers Y; Drouot X; Leu-Semenescu S; Golmard JL; Lecendreux M; Franco P; Arnulf I
    Sleep Med; 2011 Jun; 12(6):550-6. PubMed ID: 21576035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Pharmacotherapy Treatment on Patient-Reported Outcomes in a Narcolepsy and Idiopathic Hypersomnia Cohort.
    Pascoe M; Bena J; Foldvary-Schaefer N
    J Clin Sleep Med; 2019 Dec; 15(12):1799-1806. PubMed ID: 31855165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP; Kotagal S
    Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy.
    Moresco M; Pizza F; Antelmi E; Plazzi G
    Curr Drug Metab; 2018; 19(13):1073-1079. PubMed ID: 29512449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.
    Dauvilliers Y; Arnulf I; Foldvary-Schaefer N; Morse AM; Šonka K; Thorpy MJ; Mignot E; Chandler P; Parvataneni R; Black J; Sterkel A; Chen D; Skobieranda F; Bogan RK
    Lancet Neurol; 2022 Jan; 21(1):53-65. PubMed ID: 34942138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: a long-term chart review.
    Nittur N; Konofal E; Dauvilliers Y; Franco P; Leu-Semenescu S; Cock VC; Inocente CO; Bayard S; Scholtz S; Lecendreux M; Arnulf I
    Sleep Med; 2013 Jan; 14(1):30-6. PubMed ID: 23036267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial.
    Dauvilliers Y; Roth T; Bogan R; Thorpy MJ; Morse AM; Roy A; Dubow J; Gudeman J
    Sleep; 2023 Nov; 46(11):. PubMed ID: 37246913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pitolisant, a histamine H3 inverse agonist, in drug-resistant idiopathic and symptomatic hypersomnia: a chart review.
    Leu-Semenescu S; Nittur N; Golmard JL; Arnulf I
    Sleep Med; 2014 Jun; 15(6):681-7. PubMed ID: 24854887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and procrastination in post-H1N1 narcolepsy, sporadic narcolepsy and idiopathic hypersomnia, a Swedish cross-sectional study.
    Wasling HB; Bornstein A; Wasling P
    Sleep Med; 2020 Dec; 76():104-112. PubMed ID: 33152582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.
    Lopez R; Doukkali A; Barateau L; Evangelista E; Chenini S; Jaussent I; Dauvilliers Y
    Sleep; 2017 Dec; 40(12):. PubMed ID: 29099966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.
    Murali H; Kotagal S
    Sleep; 2006 Aug; 29(8):1025-9. PubMed ID: 16944670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy.
    Sleep; 2003 Feb; 26(1):31-5. PubMed ID: 12627729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary.
    Dauvilliers Y; Roth T; Bogan R; Thorpy MJ; Morse AM; Ascencion F; Gudeman J
    J Comp Eff Res; 2024 Sep; 13(9):e240031. PubMed ID: 39088033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS; Guilleminault C
    Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on treatment for idiopathic hypersomnia.
    Evangelista E; Lopez R; Dauvilliers Y
    Expert Opin Investig Drugs; 2018 Feb; 27(2):187-192. PubMed ID: 29250981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav study.
    Macfadden W; Leary EB; Fuller DS; Kirby MT; Roy A
    J Clin Sleep Med; 2024 Sep; 20(9):1467-1477. PubMed ID: 38652499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group
    J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
    Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.